Octreotide-Treated Diabetes Accompanied by Endogenous Hyperinsulinemic Hypoglycemia and Protein-Losing Gastroenteropathy
暂无分享,去创建一个
M. Haneda | Y. Kohgo | W. Motomura | N. Takahashi | M. Fujiya | Mitsuko Fukuda | M. Ieko | Miho Nagamine | A. Abiko
[1] Y. Ogawa,et al. Diagnosis and management of insulinoma. , 2013, World journal of gastroenterology.
[2] Kohjiro Ueki,et al. Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus , 2010, Journal of diabetes investigation.
[3] J. Holst,et al. Little enhancement of meal‐induced glucagon‐like peptide 1 secretion in Japanese: Comparison of type 2 diabetes patients and healthy controls , 2010, Journal of diabetes investigation.
[4] S. Libutti,et al. Localization of insulinomas to regions of the pancreas by intraarterial calcium stimulation: the NIH experience. , 2009, The Journal of clinical endocrinology and metabolism.
[5] P. Caron,et al. Short‐ and long‐term somatostatin analogue treatment in patients with hypoglycaemia related to endogenous hyperinsulinism , 2008, Clinical endocrinology.
[6] G. O’Malley,et al. Comparison of octreotide and standard therapy versus standard therapy alone for the treatment of sulfonylurea-induced hypoglycemia. , 2008, Annals of emergency medicine.
[7] Mark Ellrichmann,et al. Predictors of Incretin Concentrations in Subjects With Normal, Impaired, and Diabetic Glucose Tolerance , 2008, Diabetes.
[8] Daniel B. Jones,et al. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. , 2007, The Journal of clinical endocrinology and metabolism.
[9] P. Caron,et al. Insulin, C-peptide and proinsulin for the biochemical diagnosis of hypoglycaemia related to endogenous hyperinsulinism. , 2007, European journal of endocrinology.
[10] D. Drucker. The role of gut hormones in glucose homeostasis. , 2007, The Journal of clinical investigation.
[11] F. Ashcroft,et al. Potent and selective activation of the pancreatic beta-cell type KATP channel by two novel diazoxide analogues , 2003, Diabetologia.
[12] J. Holst,et al. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. , 2003, The Journal of clinical endocrinology and metabolism.
[13] Mark R. Burge,et al. Severe Hypoglycemia in Adults , 2003, Reviews in Endocrine and Metabolic Disorders.
[14] W. Yap,et al. Hypoglycaemia from islet cell hyperplasia and nesidioblastosis in a patient with type 2 diabetes mellitus--a case report. , 2000, Annals of the Academy of Medicine, Singapore.
[15] S. Fan,et al. Value of intra‐arterial calcium‐stimulated venous sampling for regionalization of pancreatic insulinomas , 2000, Surgery.
[16] M. Farthing,et al. Octreotide in the treatment of intestinal lymphangiectasia. , 1998, European journal of gastroenterology & hepatology.
[17] S. Tsagarakis,et al. Regionalization of occult pancreatic insulinomas with the arterial stimulation venous sampling (ASVS) technique , 1997, Clinical endocrinology.
[18] S. Libutti,et al. Intraarterial calcium stimulation and intraoperative ultrasonography in the localization and resection of insulinomas. , 1997, Surgery.
[19] H. Koshiyama,et al. Localization of insulinomas by selective intraarterial calcium injection. , 1996, The Journal of clinical endocrinology and metabolism.
[20] J. Škrha,et al. Comparison of Insulin Sensitivity in Patients with Insulinoma and Obese Type 2 Diabetes Mellitus , 1996, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[21] T. Schacker,et al. Clinical and Epidemiologic Features of Primary HIV Infection , 1996, Annals of Internal Medicine.
[22] D. Fraker,et al. Localization of Insulinomas to Regions of the Pancreas by Intra-arterial Stimulation with Calcium , 1995, Annals of Internal Medicine.
[23] M. Imamura,et al. Usefulness of selective arterial calcium injection test and secretin test in patients with insulinoma , 1994 .
[24] C. W. Garner,et al. Insulin stimulates the degradation of IRS-1 in 3T3-L1 adipocytes. , 1993, Biochemical and biophysical research communications.
[25] J. Holst,et al. Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy , 1991, Digestive Diseases and Sciences.
[26] G. Giustina,et al. Effect of a new long-acting somatostatin analogue (SMS 201–995) on glycemic and hormonal profiles in insulin-treated type II diabetic patients , 1988, Journal of endocrinological investigation.
[27] L. Kvols,et al. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. , 1986, The New England journal of medicine.
[28] J. Farndon,et al. Diazoxide in the management of patients with insulinoma , 1986, World Journal of Surgery.
[29] T. A. Schultz,et al. Clinical evaluation of somatostatin as a potential adjunct to insulin in the management of diabetes mellitus , 1977, Diabetologia.
[30] H. Kuzuya,et al. Hypoglycemia and endogenous hyperinsulinism complicating diabetes mellitus. Application of the C-peptide assay to diagnosis and therapy. , 1975, The American journal of medicine.
[31] J. Howard,et al. Hyperinsulinism and islet cell tumors of the pancreas; with 398 recorded tumors. , 1950, International abstracts of surgery.
[32] G. Laidlaw. Nesidioblastoma, the islet tumor of the pancreas. , 1938, The American journal of pathology.
[33] W. Knoefel,et al. Adult diffuse nesidioblastosis: genetically or environmentally induced? , 2008, Human pathology.
[34] T. Yamanaka,et al. Usefulness of the combination of pre- and intraoperative selective intraarterial calcium injection to detect residual insulinomas. , 2001, Internal medicine.
[35] K. Ibukuro. Vascular anatomy of the pancreas and clinical applications , 2001, International journal of gastrointestinal cancer.
[36] E. Rubin. Hypoglycemic disorders. , 1995, The New England journal of medicine.
[37] S. Bloom,et al. Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases. , 1985, Gastroenterology.